Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
SWOG Cancer Research Network
With
OBJECTIVES: * Assess the complete remission rate in patients with recurrent or refractory non-T-cell acute lymphocytic leukemia when treated with 506U78. * Determine the frequency and severity of toxic effects of this drug in these patients. OUTLINE: This is a multicenter study. Patients receive 506U78 IV over 2 hours on days 1, 3, and 5. Treatment continues every 21 days for up to 4 courses in the absence of disease progression or unacceptable toxicity. Patients are followed every month for 6 months, every 3 months for 1 year, and then every 6 months for 3.5 years. PROJECTED ACCRUAL: A total of 20-35 patients will be accrued for this study within 18 months.
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted